Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Old dogma, new tricks--21st Century phage therapy.

Literature DB >> 14704699

Old dogma, new tricks--21st Century phage therapy.

Abstract

As antibiotic resistant bacteria threaten a public health crisis, biotechnology is turning to bacteriophages, nature's tiniest viruses. But can phage therapy overcome its historical baggage?

Mesh：

Substances：
DNA

Year: 2004 PMID： 14704699 DOI： 10.1038/nbt0104-31

Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908

Keyword Cloud
Cited

51 in total

1. Enumeration of bacteriophage particles: Comparative analysis of the traditional plaque assay and real-time QPCR- and nanosight-based assays.

Authors: Bradley Anderson; Mohammed H Rashid; Chandi Carter; Gary Pasternack; Chythanya Rajanna; Tamara Revazishvili; Timothy Dean; Andre Senecal; Alexander Sulakvelidze
Journal: Bacteriophage Date: 2011-03

2. The phage therapy paradigm: prêt-à-porter or sur-mesure?

Authors: Jean-Paul Pirnay; Daniel De Vos; Gilbert Verbeken; Maia Merabishvili; Nina Chanishvili; Mario Vaneechoutte; Martin Zizi; Geert Laire; Rob Lavigne; Isabelle Huys; Guy Van den Mooter; Angus Buckling; Laurent Debarbieux; Flavie Pouillot; Joana Azeredo; Elisabeth Kutter; Alain Dublanchet; Andrzej Górski; Revaz Adamia
Journal: Pharm Res Date: 2010-11-10 Impact factor: 4.200

3. The cell lysis activity of the Streptococcus agalactiae bacteriophage B30 endolysin relies on the cysteine, histidine-dependent amidohydrolase/peptidase domain.

Authors: David M Donovan; Juli Foster-Frey; Shengli Dong; Geneviève M Rousseau; Sylvain Moineau; David G Pritchard
Journal: Appl Environ Microbiol Date: 2006-07 Impact factor: 4.792

4. Targeting Enterococcus faecalis biofilms with phage therapy.

Authors: Leron Khalifa; Yair Brosh; Daniel Gelman; Shunit Coppenhagen-Glazer; Shaul Beyth; Ronit Poradosu-Cohen; Yok-Ai Que; Nurit Beyth; Ronen Hazan
Journal: Appl Environ Microbiol Date: 2015-02-06 Impact factor: 4.792

Review 5. Novel approaches to developing new antibiotics for bacterial infections.

Authors: A R M Coates; Y Hu
Journal: Br J Pharmacol Date: 2007-08-20 Impact factor: 8.739

6. Phage as an antimicrobial agent: d'Herelle's heretical theories and their role in the decline of phage prophylaxis in the West.

Authors: Dottore Emiliano Fruciano; Shawna Bourne
Journal: Can J Infect Dis Med Microbiol Date: 2007-01 Impact factor: 2.471

Old dogma, new tricks--21st Century phage therapy.

1. Enumeration of bacteriophage particles: Comparative analysis of the traditional plaque assay and real-time QPCR- and nanosight-based assays.

2. The phage therapy paradigm: prêt-à-porter or sur-mesure?

3. The cell lysis activity of the Streptococcus agalactiae bacteriophage B30 endolysin relies on the cysteine, histidine-dependent amidohydrolase/peptidase domain.

4. Targeting Enterococcus faecalis biofilms with phage therapy.

Review 5. Novel approaches to developing new antibiotics for bacterial infections.

6. Phage as an antimicrobial agent: d'Herelle's heretical theories and their role in the decline of phage prophylaxis in the West.

7. Characterization of Salmonella bacteriophages isolated from swine lagoon effluent.

8. Predicting in vivo efficacy of therapeutic bacteriophages used to treat pulmonary infections.

9. Antipseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung.

10. Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii.